Gene · 1048
Papers3,868
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,868
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel cancer-associated secretory cells and IL-1β+ macrophages as key players in early lung adenocarcinoma progression in female never-smokers. | Clin Transl Med | 2025 | 40824728 | PubTator, text mining | PubMed |
| Stabilization of human RNA and DNA in stool samples at room temperature. | Biotechniques | 2025 | 40824169 | PubTator, text mining | PubMed |
| Small Intestinal Adenocarcinoma Presenting With Internal High Echoes: A Case Report. | Cureus | 2025 | 40821307 | PubTator, text mining | PubMed |
| Case Report: Treatment of delayed tremor episodes in a patient with DPPX antibody encephalitis. | Front Immunol | 2025 | 40808961 | PubTator, text mining | PubMed |
| Differentiating low tumor burden from oligometastatic disease in colorectal cancer: a call for individualized therapeutic approaches. | ESMO Open | 2025 | 40803019 | PubTator, text mining | PubMed |
| Nanovaccine targeting in colorectal cancer: a multi-dataset analysis of CEA expression, cytokine profiles, and co-expressed genes. | Med Pharm Rep | 2025 | 40786198 | PubTator, text mining | PubMed |
| Identification and validation of cell phagocytosis-related genes for prognosis in breast cancer: A study of diagnostic relevance in breast cancer. | Medicine (Baltimore) | 2025 | 40760619 | PubTator, text mining | PubMed |
| New Insights into Potential Therapeutic Targets for Neuroendocrine Prostate Cancer: From Bench to Clinic. | Research (Wash D C) | 2025 | 40746825 | PubTator, text mining | PubMed |
| Precemtabart tocentecan, an anti-CEACAM5 antibody-drug conjugate, in metastatic colorectal cancer: a phase 1 trial. | Nat Med | 2025 | 40739424 | PubTator, text mining | PubMed |
| The Role of Mucins in Cancer and Cancer Progression: A Comprehensive Review. | Curr Issues Mol Biol | 2025 | 40699805 | PubTator, text mining | PubMed |
| Rapid diagnostic imaging and targeted immunotoxin delivery in aggressive prostate cancer using CEACAM5-specific nanobodies. | J Nanobiotechnology | 2025 | 40682047 | PubTator, text mining | PubMed |
| [Integration of multisource transcriptomics data to identify potential biomarkers of asthmatic epithelial cells]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2025 | 40670133 | PubTator, text mining | PubMed |
| Advancing precision antibody-drug conjugate therapy: unique proteogenomic profiles of tumor subsets in non-small cell lung cancer. | Exp Hematol Oncol | 2025 | 40646627 | PubTator, text mining | PubMed |
| Proteomic Landscape of Colorectal Cancer Derived Liver Metastasis Reveals Three Distinct Phenotypes With Specific Signaling and Enhanced Survival. | Mol Cell Proteomics | 2025 | 40617497 | PubTator, text mining | PubMed |
| PTX3 as a diagnostic and prognostic biomarker in lung adenocarcinoma: a comprehensive analysis. | Discov Oncol | 2025 | 40537732 | PubTator, text mining | PubMed |
| Night shift work and lung cancer risk: a prospective cohort study with mediator analysis from the UK Biobank. | Sleep | 2025 | 40488442 | PubTator, text mining | PubMed |
| HPV6-Induced Gene Expression Signature in Recurrent Respiratory Papillomatosis. | Laryngoscope | 2025 | 40481740 | PubTator, text mining | PubMed |
| Plasma proteomic profiles for early detection and risk stratification of non-small cell lung carcinoma: A prospective cohort study with 52,913 participants. | Int J Cancer | 2025 | 40480837 | PubTator, text mining | PubMed |
| Diagnostic Significance in Estimating Tumor Burden Using Extracellular Salivary Biomarkers in Gastric Cancer Patients. | J Clin Med | 2025 | 40429589 | PubTator, text mining | PubMed |
| TRIM29 upregulation contributes to chemoresistance in triple negative breast cancer via modulating S100P-β-catenin axis. | Cell Commun Signal | 2025 | 40420099 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1048/papers?page=7